Evaluation of Mediastinal Lymph Nodes in Sarcoidosis, Sarcoid Reaction, and Malignant Lymph Nodes Using CT and FDG-PET/CT

被引:22
|
作者
Koo, Hyun Jung [1 ,2 ]
Kim, Mi Young [1 ,2 ]
Shin, So Youn [1 ,2 ]
Shin, Sooyoung [3 ]
Kim, Sung-Soo [4 ]
Lee, Sei Won [5 ]
Choi, Chang-Min [5 ,6 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul 138736, South Korea
[3] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
[4] Cheongju Univ, Dept Healthcare Management, Cheongju, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Pulm & Crit Care Med, Seoul 138736, South Korea
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Div Oncol, Seoul 138736, South Korea
关键词
TRANSBRONCHIAL NEEDLE ASPIRATION; METASTATIC BREAST-CANCER; TNM STAGING SYSTEM; LUNG-CANCER; F-18-FDG PET/CT; DIAGNOSIS; LYMPHADENOPATHY; THERAPY; DISEASE; UTILITY;
D O I
10.1097/MD.0000000000001095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to analyze the clinical, computed tomography (CT), and positron emission tomography (PET) findings of sarcoidosis, sarcoid reaction, and malignant lymph nodes (LNs) to the results of transbronchial LN aspiration and biopsy (TBNA). The TBNA results of mediastinal and hilar LNs of 152 patients in our hospital from July 2008 to March 2013 were retrospectively reviewed. Two independent radiologists measured the size and attenuation of LNs on CT and assessed the probability of the 3 categories: sarcoidosis (n = 36), sarcoid reaction (n = 25), or malignant LNs (n = 91). The total volume and attenuation of LNs were measured using Image J (NIH). The median maximum standardized uptake value (maxSUV) of the 3 mediastinal and hilar LNs on PET/CT was obtained. There was no significantly different CT finding between sarcoidosis and sarcoid reaction. Multivariate analysis showed that the age, total volume of LNs, and number of enlarged LNs significantly differed between sarcoid reaction and malignant LNs. Sarcoid reaction tends to be occurred in young patients (P = 0.007), the total volume of LNs was smaller (P = 0.04) than that of malignant LNs, and there were significantly more LNs >1 cm (P = 0.005). The median maxSUV of the 3 highest SUVs of the LNs did not significantly differ between the 3 entities.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Can artificial intelligence distinguish between malignant and benign mediastinal lymph nodes using sonographic features on EBUS images?
    Ozcelik, Neslihan
    Ozcelik, Ali Erdem
    Bulbul, Yilmaz
    Oztuna, Funda
    Ozlu, Tevfik
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (12) : 2019 - 2024
  • [42] Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
    Nakayama, Michihiro
    Okizaki, Atsutaka
    Ishitoya, Shunta
    Sakaguchi, Miki
    Sato, Junichi
    Aburano, Tamio
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (02) : 163 - 169
  • [43] A Nomogram to Predict Benign/Malignant Mediastinal Lymph Nodes Based on EBUS Sonographic Features
    Ling, Bingchao
    Xie, Weishun
    Zhong, Yi
    Feng, Taowen
    Huang, Yueli
    Ge, Lianying
    Liu, Aiqun
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2024, 2024
  • [44] CT texture analysis and node-RADS CT score of mediastinal lymph nodes-diagnostic performance in lung cancer patients
    Meyer, Hans-Jonas
    Schnarkowski, Benedikt
    Pappisch, Johanna
    Kerkhoff, Teresa
    Wirtz, Hubert
    Hoehn, Anne-Kathrin
    Kraemer, Sebastian
    Denecke, Timm
    Leonhardi, Jakob
    Frille, Armin
    CANCER IMAGING, 2022, 22 (01)
  • [45] Quantitative CT texture and shape analysis: Can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer?
    Hamid Bayanati
    Rebecca E. Thornhill
    Carolina A. Souza
    Vineeta Sethi-Virmani
    Ashish Gupta
    Donna Maziak
    Kayvan Amjadi
    Carole Dennie
    European Radiology, 2015, 25 : 480 - 487
  • [46] Quantitative CT texture and shape analysis: Can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer?
    Bayanati, Hamid
    Thornhill, Rebecca E.
    Souza, Carolina A.
    Sethi-Virmani, Vineeta
    Gupta, Ashish
    Maziak, Donna
    Amjadi, Kayvan
    Dennie, Carole
    EUROPEAN RADIOLOGY, 2015, 25 (02) : 480 - 487
  • [47] Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT
    Phan Nguyen
    Bhatt, Manoj
    Bashirzadeh, Farzad
    Hundloe, Justin
    Ware, Robert
    Fielding, David
    Kumar, Aravind S. Ravi
    RESPIROLOGY, 2015, 20 (01) : 129 - 137
  • [48] Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study
    Miao, Huang
    Shaolei, Li
    Nang, Li
    Yumei, Lai
    Shanyuan, Zhang
    Fangliang, Lu
    Yue, Yang
    THORACIC CANCER, 2019, 10 (06) : 1453 - 1460
  • [49] Evaluation of 18FDG PET-CT-positive mediastinal-hilar lymph nodes in extrathoracic malignancies by EBUS-TBNA; correlation of SUVmax, and short-axis diameter with the final diagnosis
    Luthra, Kunal
    Singh, Jyoti
    INDIAN JOURNAL OF CANCER, 2023, 60 (01) : 106 - 113
  • [50] 18F-FDG PET/CT texture analysis of anthracotic lymph nodes detected with EBUS and comparison with cytological findings
    Falay, Fikri Okan
    Mericoz, Cisel Aydin
    Demirtas, Elif
    Bulutay, Pinar
    Seymen, Hulya
    Firat, Pinar
    Demirkor, Mehmet Onur
    Caglayan, Benan
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (02) : 148 - 154